CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 653-659

  Pusalkar, Madhavi ^a   Meherji, Pervin ^a   Gokral, Jyotsna ^a   Chinnaraj, Saravanan ^a   Maitra, Anurupa ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

CYP11A1; CYP17; hyperandrogenemia; PCOS

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450 17; HYDROXYPROGESTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERANDROGENISM; INDIAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; TESTOSTERONE BLOOD LEVEL;

CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERANDROGENISM; INCIDENCE; INDIA; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; YOUNG ADULT;

EID: 67651097796     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.016     Document Type: Article

References (40)

1. Clayton R., Ogden V., Hodgkinson J., Worswick L., Rodin D., Dyer S., et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?. Clin Endocrinol (Oxf) 37 (1992) 127-134
2. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
3. Polson D.W., Adams J., Wadsworth J., and Franks S. Polycystic ovaries a common finding in normal women. Lancet 8590 (1988) 870-872
4. Carmina E., and Lobo R.A. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84 (1999) 1879-1899
5. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2754-2759
6. Conway G.S., Honour J.W., and Jacob H.S. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 30 (1989) 459-470
7. Crosignani P.G., and Nicolosi A.G. Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update 7 (2001) 3-7
8. Cooper H., Spellacy W., Prem K., and Cohen W. Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol 100 (1968) 371-387
9. Ferriman D., and Purdie A.W. The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11 (1979) 291-300
10. Givens J.R. Familial polycystic ovarian disease. Endocrinol Metab Clin North Am 17 (1988) 771-783
11. Hague W.M., Adams J., Reeders S.T., Peto T.E., and Jacobs H.S. Familial polycystic ovaries: a genetic disease?. Clin Endocrinol (Oxf) 29 (1988) 593-605
12. Lunde O., Magnus P., Sandvik L., and Hoglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 28 (1989) 23-30
13. Carey A.H., Chan K.L., Short F., White D., Williamson R., and Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38 (1993) 653-658
14. Franks S., Gharani N., Waterworth D., Batty S., White D., Williamson R., et al. The genetic basis of polycystic ovary syndrome. Hum Reprod 12 (1997) 2641-2648
15. Govind A., Obhrai M.S., and Clayton R.N. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84 (1999) 38-43
16. Kahsar-Miller M.D., Nixon C., Boots L.R., Go R.C., and Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75 (2001) 53-58
17. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
18. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 81 (2004) 19-25
19. Maitra A., Meherji P., Desai M., Gokral J., Donde U., and Joshi U. Lipoprotein lipids in androgen excess-a study among Indian women. Int J Fertil 39 (1994) 218-222
20. Maitra A., Pingle R., Menon P., Gokral J., and Meherji P. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women. Int J Fertil Womens Med 46 (2001) 271-277
21. Abbott D., Barnett D., Bruns C., and Dumesic D. Androgen excess in fetal programming of female reproduction: a developmental etiology for polycystic ovary syndrome?. Hum Reprod Update 11 (2005) 357-374
22. Nelson V.L., Legro R.S., Strauss III J.F., and McAllister J.M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13 (1999) 946-957
23. Urbanek M., Legro R., Driscoll D., Azziz R., Ehrmann D., Norman R., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Nat Acad Sci USA 96 (1999) 8573-8578
24. Gharani N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6 (1997) 397-402
25. Rosenfield R.L., Barnes R.B., Cara J.F., and Lucky A.W. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril 53 (1990) 785-791
26. Ehrmann D.A., Rosenfield R.L., Barnes R.B., Brigell D.F., and Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327 (1992) 157-162
27. Wickenheisser J.K., Quinn P.G., Nelson V.L., Legro R.S., Strauss III J.F., and McAllister J.M. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroid acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 85 (2000) 2304-2311
28. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3 (1994) 1873-1876
29. Techatraisak K., Conway G.S., and Rumsby G. Frequency of a polymorphism in the regulatory region of the 17 alpha-hydroxylase-17, 20-lyase (CYP17) gene in hyperandrogenic states. Clin Endocrinol (Oxf) 46 (1997) 131-134
30. Diamanti-Kandarakis E., Bartzis M.I., Zapanti E., Spina G., Filandra F., Tsianateli T.C., et al. Polymorphism T→C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 71 (1999) 431-435
31. Diamanti-Kandarakis E., Bartzis M.I., Bergiele A.T., Tsianateli T.C., and Kouli C.R. Microsatellite polymorphism (tttta)(n) at -528 bp of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 73 (2000) 735-741
32. Maitra A., Pusalkar M., Gokral J., and Meherji P. Mutational analysis of CYP11A1 and leptin as genetic determinants of hyperandrogenicity and obesity in PCOS: study in an Indian cohort group. International Congress Series 1271 (2004) 38-41
33. San Millian J.L., Sancho J., Calvo R.M., and Escobar-Morreale H.F. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 75 (2001) 797-802
34. Daneshmand S., Weitsman S., Navab A., Jakimiuk A., and Magiffin D. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17 alpha-hydroxylase/C (17-20) lyase promoters. Fertil Steril 77 (2002) 274-280
35. Gaasenbeek M., Powell B., Sovio U., Haddad L., Gharani N., Bennett A., et al. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome and serum testosterone. J Clin Endocrinol Metab 89 (2004) 2408-2413
36. Wang Y., Wu X., Cao Y., Yi L., and Chen J. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome. Fertil Steril 86 (2006) 223-226
37. Jahanfar S., Eden J.A., Warren P., Seppala M., and Naguyen T.V. A twin study of polycystic ovary syndrome. Fertil Steril 63 (1995) 478-486
38. Sarkar C., and Maitra A. Deciphering the cis- regulatory elements of co-expressed genes in PCOS by in silico analysis. Gene 408 (2008) 72-84
39. Wood J., Nelson V., Ho C., Jansen E., Wang C., Urbanek M., et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278 (2003) 26380-26390
40. Fluck C., and Miller W. GATA-4 and GATA-6 modulate tissue specific transcription of the human gene for P450c17 by direct interaction with SP1. Mol Endocrinol 18 (2004) 1144-1157